Thermo Fisher Scientific (TMO) Share-based Compensation (2009 - 2026)

Thermo Fisher Scientific has disclosed Share-based Compensation across 18 years of filings, most recently posting $83.0 million for Q1 2026.

• Quarterly Share-based Compensation rose 10.67% year-over-year to $83.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $318.0 million (up 3.92% YoY) and the FY2025 annual result came in at $310.0 million, up 2.99% from the prior year.
• Share-based Compensation declined to $83.0 million in Q1 2026, from $84.0 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $84.0 million in Q2 2024 and troughed at $61.0 million in Q4 2023.
• A 5-year average of $75.2 million and a median of $76.0 million in 2023 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation surged 52.94% — and 2023, when it decreased 18.67%.
• Tracing TMO's Share-based Compensation over 5 years: stood at $75.0 million in 2022, then retreated by 18.67% to $61.0 million in 2023, then rose by 29.51% to $79.0 million in 2024, then gained by 6.33% to $84.0 million in 2025, then declined by 1.19% to $83.0 million in 2026.
• Business Quant data shows TMO's Share-based Compensation at $83.0 million in Q1 2026, $84.0 million in Q4 2025, and $70.0 million in Q3 2025.